- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02047825
Upper Limbs Intervention in Multiple Sclerosis
Intervention Focused on Lower Limbs and Functionality in Patients With Multiple Sclerosis
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The total estimated prevalence rate of multiple sclerosis has been reported to be 83 per 100 000 for the past three decades. It is also higher in northern countries and between females with a male ratio around 2.0. The highest prevalence rates have been estimated for the age group 35-64 years. The estimated European mean annual Multiple Sclerosis incidence rate is 4.3 cases per 100 000.
Multiple sclerosis can cause a variety of symptoms: hypoesthesia, muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; dysarthria, dysphagia, visual problems fatigue and acute or chronic pain syndromes, bladder and bowel difficulties,cognitive impairment, or emotional symptomatology. The investigators focus on the benefits of an intervention on dexterity, strength, coordination and functionality.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Granada, Espanha, 18071
- Faculty of Health Sciences
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients diagnosed with multiple sclerosis.
- Subjects who can complete the assessment battery of tests at the beginning and at the end of the study
Exclusion Criteria:
- Auditive and visual disturbances.
- Cognitive problems.
- Psychiatric pathology.
- Sensorial disturbances.
- Traumatic pathology of the hand.
- Concomitant neurological conditions
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Experimental group
The patients included in this group will receive an intensive intervention based on upper limbs intervention with exercises added to the usual treatment they receive.
|
An 8-week intervention with different exercises will be performed.
This intervention will focus on upper limbs.
The exercises will include plaster of resistance, elastic bands and other exercises.
Outros nomes:
|
|
Comparador Ativo: Control group
Patients with multiple sclerosis not included in the intensive intervention.
They receive the usual treatment of occupational and physical therapy.
|
Occupational therapy and physiotherapy, twice a week, as usual.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in manual dexterity
Prazo: baseline, 8 weeks
|
Changes from baseline to postintervention in manual dexterity assessed by the Purdue Pegboard test and coin rotation task.
The Purdue pegboard test is a timed physical test used to measure manual dexterity.
Test subjects are asked to place small pins into holes in the pegboard using a specific hand and following a specific process.
The coin rotation task consists of rotate the coin during 10 seconds.
|
baseline, 8 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in apraxia
Prazo: baseline, 8 weeks
|
Changes in apraxia from baseline to postintervention is going to be measured using the Apraxia Screen of Tulia.
This is a screening test of upper limbs apraxia.
|
baseline, 8 weeks
|
|
Changes in grip strength
Prazo: baseline, 8 weeks
|
The changes in the grip strength will be measured using a Jamar dynamometer with a standard protocol allowing three attempts on each side.
During each measurement, patients were sitting with their shoulder adducted and elbow flexed to 90°.
The maximum value achieved from all six attempts was used in analyses.
kg/cm2.
|
baseline, 8 weeks
|
|
Change in fatigue
Prazo: baseline, 8 weeks
|
The fatigue change is going to be measured using the Fatigue Severity Scale, a 9-item scale focus on the severity of fatigue and how much it affects the person's activities and lifestyle in the patients.
|
baseline, 8 weeks
|
|
Upper limb functioning
Prazo: baseline, 8 weeks
|
The upper limb functioning is going to be measured with the Action Research Arm Test, it is a 19 item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement).
|
baseline, 8 weeks
|
|
Pinch strength
Prazo: baseline, 8 weeks
|
Pinch strength is going to be measured using a pinch dynamometer.
The participants were asked to perform three repetitions on each side with five seconds rest provided between the measures.
This was performed using the alternating-hands method, which allows rest between repetitions as the examiner records information and provides instructions for the alternate hand.
Three pinchs were evaluated: lateral, distal and tripod pinch
|
baseline, 8 weeks
|
|
Tapping speed
Prazo: baseline, 8 weeks
|
The tapping speed will be measured with the finger tapping test.
|
baseline, 8 weeks
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Quality of life
Prazo: Baseline, 8 weeks
|
Quality of life is going to be measured using a self-reported questionnaire, the short-form Health Survey, SF-36
|
Baseline, 8 weeks
|
|
Goals achievement
Prazo: baseline, 8 weeks
|
The achievement of the goals of the intervention will be measured with the Goal Attainment Scale, a method of scoring the extent to which patient's individual goals are achieved in the course of intervention.
|
baseline, 8 weeks
|
|
Functionality
Prazo: baseline, 8 weeks
|
Functionality will be measured with the Functional Independence Measure, a questionnaire.
This is the most widely accepted functional assessment measure in use in the rehabilitation community
|
baseline, 8 weeks
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- DF0048UG
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .